UK markets closed

Lyra Therapeutics, Inc. (LYRA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.0300-0.6000 (-12.96%)
At close: 04:00PM EDT
4.2200 +0.19 (+4.71%)
After hours: 07:23PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6666
Avg. Estimate-0.32-0.31-1.29-1.2
Low estimate-0.36-0.35-1.39-1.45
High estimate-0.27-0.28-1.16-1.02
Year ago EPS-0.36-0.27-1.26-1.29
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5566
Avg. Estimate430k430k1.57M670k
Low estimate320k320k500kN/A
High estimate530k530k2.13M1.59M
Year ago sales458k370k1.56M1.57M
Sales growth (year/est)-6.10%16.20%0.80%-57.30%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.42-0.32-0.31-0.26
Actual EPS-0.36-0.27-0.22-0.35
Difference0.060.050.09-0.09
Surprise %14.30%15.60%29.00%-34.60%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.32-0.31-1.29-1.2
7 days ago-0.26-0.25-1.01-1.11
30 days ago-0.26-0.25-1.01-1.11
60 days ago-0.26-0.25-0.96-1.16
90 days ago-0.27-0.26-1.09-1.18
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/A2
Up last 30 daysN/AN/AN/A2
Down last 7 daysN/AN/AN/AN/A
Down last 30 days5564
Growth estimatesLYRAIndustrySector(s)S&P 500
Current qtr.11.10%N/AN/AN/A
Next qtr.-14.80%N/AN/AN/A
Current year-2.40%N/AN/AN/A
Next year7.00%N/AN/AN/A
Next 5 years (per annum)-1.60%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A